AU6625701A - Agent for reversal of drug resistance in mycobacterium tuberculosis - Google Patents
Agent for reversal of drug resistance in mycobacterium tuberculosisInfo
- Publication number
- AU6625701A AU6625701A AU66257/01A AU6625701A AU6625701A AU 6625701 A AU6625701 A AU 6625701A AU 66257/01 A AU66257/01 A AU 66257/01A AU 6625701 A AU6625701 A AU 6625701A AU 6625701 A AU6625701 A AU 6625701A
- Authority
- AU
- Australia
- Prior art keywords
- reversal
- agent
- drug resistance
- mycobacterium tuberculosis
- mycobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN597/MUM/2000 | 2000-06-28 | ||
IN597MU2000 | 2000-06-28 | ||
PCT/IB2001/001136 WO2002000165A2 (en) | 2000-06-28 | 2001-06-26 | Agent for reversal of drug resistance in mycobacterium tuberculosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6625701A true AU6625701A (en) | 2002-01-08 |
Family
ID=11097261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU66257/01A Abandoned AU6625701A (en) | 2000-06-28 | 2001-06-26 | Agent for reversal of drug resistance in mycobacterium tuberculosis |
Country Status (4)
Country | Link |
---|---|
AP (1) | AP2002002454A0 (en) |
AU (1) | AU6625701A (en) |
EA (1) | EA004875B1 (en) |
WO (1) | WO2002000165A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109385439A (en) * | 2018-09-18 | 2019-02-26 | 上海晶诺生物科技有限公司 | The one recombination TM4 phage library and its application for constructing nadh dehydrogenase gene family missing mycobacterium tuberculosis |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040132101A1 (en) | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
EP2345671B8 (en) | 2002-09-27 | 2023-01-11 | Xencor, Inc. | Optimized fc variants and methods for their generation |
EP1610825A2 (en) | 2003-03-31 | 2006-01-04 | Xencor, Inc. | Methods for rational pegylation of proteins |
US7610156B2 (en) | 2003-03-31 | 2009-10-27 | Xencor, Inc. | Methods for rational pegylation of proteins |
US7642340B2 (en) | 2003-03-31 | 2010-01-05 | Xencor, Inc. | PEGylated TNF-α variant proteins |
EP1697741A4 (en) | 2003-12-04 | 2008-02-13 | Xencor Inc | Methods of generating variant proteins with increased host string content and compositions thereof |
EP1737890A2 (en) | 2004-03-24 | 2007-01-03 | Xencor, Inc. | Immunoglobulin variants outside the fc region |
EP2940043A1 (en) | 2004-07-15 | 2015-11-04 | Xencor, Inc. | Optimized fc variants |
KR101027427B1 (en) | 2004-11-12 | 2011-04-11 | 젠코어 인코포레이티드 | Fc VARIANTS WITH INCREASED BINDING TO FcRn |
US8802820B2 (en) | 2004-11-12 | 2014-08-12 | Xencor, Inc. | Fc variants with altered binding to FcRn |
AU2008345242B2 (en) | 2007-10-31 | 2014-02-27 | Xencor, Inc. | Fc variants with altered binding to FcRn |
CN101810610B (en) * | 2010-04-19 | 2012-09-26 | 海南美兰史克制药有限公司 | Amoxicillin sodium flucloxacillin sodium medicine compound liposome injection |
US9988439B2 (en) | 2011-12-23 | 2018-06-05 | Nicholas B. Lydon | Immunoglobulins and variants directed against pathogenic microbes |
EP2793944A4 (en) | 2011-12-23 | 2015-09-02 | Nicholas B Lydon | Immunoglobulins and variants directed against pathogenic microbes |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5633131A (en) * | 1992-04-30 | 1997-05-27 | Institut Pasteur | Rapid detection of isoniazid resistance in mycobacterium tuberculosis probes for selecting nucleic acid encoding isoniazid resistance, and methods and kits |
US5851763A (en) * | 1992-09-17 | 1998-12-22 | Institut Pasteur | Rapid detection of antibiotic resistance in mycobacterium tuberculosis |
US5871912A (en) * | 1992-04-30 | 1999-02-16 | Institut Pasteur | Nucleic acid probes, sequences and methods for detecting mycobacterium tuberculosis resistant to isoniazid |
US5686590A (en) * | 1993-05-14 | 1997-11-11 | Agresearch, New Zealand Pastoral Agriculture Research Institute Ltd. | Methods and compositions for detecting and treating mycobacterial infections using an INHA gene |
ATE261496T1 (en) * | 1994-06-09 | 2004-03-15 | Innogenetics Nv | METHOD FOR DETECTING THE ANTIBIOTIC RESISTANCE SPECTRUM OF MYCOBACTERIA SPECIES |
US6200754B1 (en) * | 1998-03-19 | 2001-03-13 | Variagenics, Inc. | Inhibitors of alternative alleles of genes encoding products that mediate cell response to environmental changes |
-
2001
- 2001-06-26 AU AU66257/01A patent/AU6625701A/en not_active Abandoned
- 2001-06-26 WO PCT/IB2001/001136 patent/WO2002000165A2/en active Application Filing
- 2001-06-26 AP APAP/P/2002/002454A patent/AP2002002454A0/en unknown
- 2001-06-26 EA EA200200290A patent/EA004875B1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109385439A (en) * | 2018-09-18 | 2019-02-26 | 上海晶诺生物科技有限公司 | The one recombination TM4 phage library and its application for constructing nadh dehydrogenase gene family missing mycobacterium tuberculosis |
Also Published As
Publication number | Publication date |
---|---|
WO2002000165A3 (en) | 2002-06-20 |
EA200200290A1 (en) | 2002-12-26 |
EA004875B1 (en) | 2004-08-26 |
AP2002002454A0 (en) | 2002-06-30 |
WO2002000165A2 (en) | 2002-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001264313A1 (en) | Pyrazolopyridine compounds and use thereof as drugs | |
AU2001277741A1 (en) | 2-aminopyridine compounds and use thereof as drugs | |
AU2001280188A1 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
AU2001285020A1 (en) | P97-active agent conjugates and their methods of use | |
AU6625701A (en) | Agent for reversal of drug resistance in mycobacterium tuberculosis | |
AU2001269720A1 (en) | Catheter securing device and bite block | |
AU2002225356A1 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | |
AU2002241538A1 (en) | Intrasvascular drug delivery device and use therefor | |
AU2001287898A1 (en) | Pyrazolopyridines and pyrazolopyridazines as antidiabetics | |
AU2001257326A1 (en) | Topical anesthetic/opioid formulations and uses thereof | |
HUP0301417A2 (en) | Antimikrobal and contraceptive composition and their use | |
AU2002224324A1 (en) | Toilet training article containing an astringent agent | |
AU2001289308A1 (en) | Targeted agents useful for diagnostic and therapeutic applications | |
AU2002354476A1 (en) | Pyrazolopyridine derivatives and medicinal use thereof | |
GB0101035D0 (en) | Formulation and use thereof | |
AU5073101A (en) | Lipid composition and use thereof | |
AU2003281044A1 (en) | Pyrrolopyridine derivative and use thereof | |
AU2002218502A1 (en) | Lactam compounds and medicinal use thereof | |
AU2002214948A1 (en) | Heterocyclylalkyl azole derivatives and use thereof as pesticidal agents | |
AU2001233176A1 (en) | Resistance sequences and uses thereof | |
AU2001251702A1 (en) | Personal drug testing kit | |
AU1053501A (en) | Polyazanaphthalene compound and medicinal use thereof | |
AUPQ462299A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
AU4432001A (en) | Trityl-type compounds and their use | |
AU6835300A (en) | Diagnostic kit and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |